Zai Lab Partner, MacroGenics, Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice